ENTBF (Entheon Biomedical) Capex-to-Operating-Income : 0.00 (As of Feb. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Entheon Biomedical Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Entheon Biomedical's Capital Expenditure for the three months ended in Feb. 2025 was $0.00 Mil. Its Operating Income for the three months ended in Feb. 2025 was $-0.10 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

Entheon Biomedical Capex-to-Operating-Income Historical Data

The historical data trend for Entheon Biomedical's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Entheon Biomedical Capex-to-Operating-Income Chart

Entheon Biomedical Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Nov21

Nov22

Nov23

Nov24

Capex-to-Operating-Income

Get a 7-Day Free Trial

Entheon Biomedical Quarterly Data
	Mar20	Jun20	Sep20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25
Capex-to-Operating-Income	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Entheon Biomedical's Capex-to-Operating-Income

For the Biotechnology subindustry, Entheon Biomedical's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Entheon Biomedical's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entheon Biomedical's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Entheon Biomedical's Capex-to-Operating-Income falls into.

Save Embed

;

Save Embed

;

Entheon Biomedical Capex-to-Operating-Income Calculation

Entheon Biomedical's Capex-to-Operating-Income for the fiscal year that ended in Nov. 2024 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	-0.238
	=	N/A

Entheon Biomedical's Capex-to-Operating-Income for the quarter that ended in Feb. 2025 is calculated as

Capex-to-Operating-Income	=	- Capital Expenditure	/	Operating Income
	=	- (0)	/	-0.104
	=	N/A

Entheon Biomedical (OTCPK:ENTBF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

Entheon Biomedical Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Entheon Biomedical's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.